Free Trial
LON:EKF

EKF Diagnostics 3/25/2025 Earnings Report

EKF Diagnostics logo
GBX 20.60 -0.20 (-0.96%)
As of 11:06 AM Eastern

EKF Diagnostics EPS Results

Actual EPS
GBX 1.38
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

EKF Diagnostics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

EKF Diagnostics Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

EKF Diagnostics Earnings Headlines

Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
See More EKF Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like EKF Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on EKF Diagnostics and other key companies, straight to your email.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

View EKF Diagnostics Profile

More Earnings Resources from MarketBeat